Foster Group 13F: Exits Stryker (SYK) Stake
Foster Group fully divested its Stryker Corporation holdings, selling all 751 shares.
Reviewed by automated data checks against the source filing. How we make and check alerts
Foster Group sold its entire stake of 751 shares in Stryker Corporation ($SYK), according to a 13F filing with the SEC dated October 13, 2026.
Since the filing, $SYK is up 4.3% to date (from the $282.55 close on Oct 13, 2026).
SYK
Stryker Corporation
Key Points
- Foster Group sold all 751 shares of Stryker Corporation, exiting the position entirely.
- Stryker, a medical device company, has a market cap of about $105.2 billion and a P/E ratio of 28.4.
- Stryker pays a $3.52 annual dividend, yielding 1.28% with a payout ratio of 36.1%.
Get $SYK trade alerts by text
We text you when insiders, Congress or big funds trade $SYK. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Stryker Corporation alert may contain errors. Disclosures
Foster Group has fully exited its position in Stryker Corporation (NYSE:SYK), as per its latest Form 13F filing with the SEC. The fund sold all 751 shares it previously held, marking a 100% reduction in its stake.
Foster Group vs. the S&P 500
Hypothetical returns from Foster Group's disclosed trades, not real profit or advice. How we model this.
What Changed in Foster Group's Stryker Position
Foster Group closed its position in Stryker Corporation by selling all 751 shares it owned. This move reflects a complete divestment, as the fund no longer holds any shares of the medical device company.
Stryker Corporation Stock Up 4.5%
As of Friday, shares of Stryker Corporation were trading near their previous close of $275.12. The company, which operates in the healthcare sector, boasts a market capitalization of approximately $105.2 billion. With a P/E ratio of 28.4 and a forward P/E of 16.4, Stryker's stock has a beta of 0.768, indicating lower volatility compared to the broader market. The stock's 52-week range spans from $267 to $392.55, with a 50-day moving average of $319.28 and a 200-day moving average of $333.93. Stryker maintains a current ratio of 2.157 and a quick ratio of 1.08, with a debt-to-equity ratio of 64.39.
Recent Earnings
Stryker Corporation reported revenue of $25.8 billion, with a growth rate of 9.4%. The company achieved a net margin of 14.4% and a return on equity of 16.5%. Earnings per share stood at $9.66. Investors can anticipate the next earnings report on October 29, 2026.
Dividend
Stryker pays an annual dividend of $3.52 per share, yielding 1.28%. The dividend payout ratio is 36.1%, reflecting the portion of earnings distributed to shareholders. The company continues to provide a steady income stream for its investors.
About Stryker Corporation
Stryker Corporation, headquartered in Portage, Michigan, is a leading medical technology company. It operates through two main segments: MedSurg and Neurotechnology, and Orthopaedics. The company offers a wide range of products including surgical equipment, patient safety technologies, and implants for joint replacements. Stryker serves healthcare facilities globally and employs around 56,000 people. Under the leadership of CEO Kevin A. Lobo, Stryker continues to innovate in the medical devices industry.
Bottom Line
Foster Group's decision to sell out of Stryker Corporation is a notable move, reflecting a complete withdrawal from the stock. Investors often track such filings to gauge fund sentiment, though 13F filings are backward-looking and may not represent current positions. Stryker remains a significant player in the medical technology sector, offering a strong dividend and robust earnings growth.
Related Filing Alerts
Source: Foster Group's 13F filing on $SYK (Oct 13, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Foster Group 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts